Co-Authors
This is a "connection" page, showing publications co-authored by Weifan Zheng and Kevin Williams.
Connection Strength
0.835
-
Salim EA, Ji X, Tarpley M, Dixon MS, Zheng W, Scott JE, Williams KP. From in silico prediction to experimental validation: Identification of drugs and novel synergistic combinations that inhibit growth of inflammatory breast cancer cells. bioRxiv. 2025 Dec 16.
Score: 0.242
-
Abu Rabe D, Chdid L, Lamson DR, Laudeman CP, Tarpley M, Elsayed N, Smith GR, Zheng W, Dixon MS, Williams KP. Identification of Novel GANT61 Analogs with Activity in Hedgehog Functional Assays and GLI1-Dependent Cancer Cells. Molecules. 2024 Jun 28; 29(13).
Score: 0.218
-
Ji X, Williams KP, Zheng W. Applying a Gene Reversal Rate Computational Methodology to Identify Drugs for a Rare Cancer: Inflammatory Breast Cancer. Cancer Inform. 2023; 22:11769351231202588.
Score: 0.208
-
Ji X, Jin C, Dong X, Dixon MS, Williams KP, Zheng W. Literature-Wide Association Studies (LWAS) for a Rare Disease: Drug Repurposing for Inflammatory Breast Cancer. Molecules. 2020 Aug 28; 25(17).
Score: 0.167